Granules India get US FDA’s approval for another ANDA capsule, shares dip
Granules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP,
Continue readingThe Number One Finance & Business Blog!
Granules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP,
Continue readingBlock deals continue to galore at the exchanges. If media reports are to believed, Antfin is likely to sell another 3.6 per
Continue reading